Jill Howe

Jill Howe

Director of Finance/CFO at ASTERIAS BIOTHERAPEUTICS INC

Net worth: 33 915 $ as of 30/05/2026

50 year
Health Technology
Consumer Services
Health Services

Profile

Jill Ann Howe is currently Director at MUSC Foundation for Research Development, Independent Director at Biora Therapeutics, Inc. since 2021, Chief Financial Officer at Lineage Cell Therapeutics, Inc. since 2022, and Chief Financial Officer at Asterias Biotherapeutics, Inc. Former positions include Director at Codagenix, Inc. from 2021 to 2025, Finance Director & Controller at Amplyx Pharmaceuticals, Inc. from 2016 to 2017, Finance Director & Controller at Somaxon Pharmaceuticals, Inc. from 2006 to 2013, Finance Director & Controller at Receptos LLC from 2013 to 2016, Chief Financial Officer at DTx Pharma, Inc. from 2021 to 2022, and Treasurer & VP-Finance at Gossamer Bio, Inc. from 2018 to 2021.
Education includes undergraduate studies at San Diego State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
19/04/2026 25,500 ( 0.01% ) 33 915 $ 30/05/2026

Jill Howe active positions

CompaniesPositionStart
BIORA THERAPEUTICS, INC. Director/Board Member 02/11/2021
LINEAGE CELL THERAPEUTICS, INC. Director of Finance/CFO 13/11/2022
ASTERIAS BIOTHERAPEUTICS INC Director of Finance/CFO -
MUSC Foundation for Research Development
Director/Board Member -

Former positions of Jill Howe

CompaniesPositionEnd
Director/Board Member 28/02/2025
Director of Finance/CFO 30/06/2022
GOSSAMER BIO, INC. Treasurer 31/05/2021
Director of Finance/CFO 30/11/2017
RECEPTOS INC Director of Finance/CFO 29/02/2016
See the detail of Jill Howe's experience

Training of Jill Howe

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

52

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

MUSC Foundation for Research Development

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!